Last updated: August 5, 2025
Introduction
Patent KR20140081761 represents a significant intellectual property asset within South Korea’s robust pharmaceutical patent landscape. Derived from a detailed patent application filed with the Korean Intellectual Property Office (KIPO), this patent underscores innovations in drug formulations, methods of treatment, or novel compounds. Analyzing its scope, specific claims, and its standing within South Korea's patent ecosystem provides vital insights for industry stakeholders, including pharmaceutical companies, generic manufacturers, and patent strategists.
Patent Overview and Filing Context
KR20140081761, assigned a publication number in 2014, documents an inventive step in the realm of pharmaceuticals, possibly targeting a novel therapeutic compound, a formulation optimization, or an innovative treatment methodology. The patent's substantive claims define proprietary rights and are critical for understanding their breadth and enforceability.
The filing indicates a strategic move by the patent holder to secure market exclusivity in South Korea, a country known for a dynamic patent landscape aligned with its robust pharmaceutical industry and active R&D environment.
Scope of Patent KR20140081761
The scope of a patent primarily hinges on its claims, which delineate the boundaries of the exclusive rights granted. A broad scope offers comprehensive protection, deterring competitors, but risks narrower claims if prior art is cited during examination. Conversely, narrow claims may offer limited rights but are easier to defend.
The Claims Structure:
Patent KR20140081761 likely comprises independent claims covering core innovations and dependent claims narrow enough to specify particular embodiments, formulations, or methods.
Independent Claims
Typically, the independent claims in such a patent could include:
- Compound Claims: Covering a specific chemical entity or class of compounds with therapeutic activity, possibly including their salts, esters, or derivatives.
- Method Claims: Detailing a novel method of synthesis, formulation, or treatment using the compound.
- Use Claims: Specialized uses of the compound for treating particular diseases.
Example (hypothetical):
"An isolated chemical compound with a specified structure, or a pharmaceutically acceptable salt thereof, for use in treating [target disease]."
Claim Language and Limitations:
The claims likely specify chemical structural parameters, dosage forms, or treatment modes. Precision in language — such as inclusion of Markush groups or functional limitations — directly affects the patent's reach.
Dependent Claims
Dependent claims probably detail specific variants, such as:
- Specific substituents or substitutions within the compound’s core structure.
- Particular formulations (e.g., extended-release capsules).
- Processing conditions or manufacturing methods.
Patent Claims Analysis
Claim Breadth and Validity:
-
Scope & Breadth:
The claims' breadth directly correlates with their strength. Broader claims covering a class of compounds or methods could provide formidable market exclusivity but face higher invalidity risks, especially if prior art references disclose similar compounds or techniques.
-
Novelty & Inventive Step:
For patent KR20140081761 to be granted, it must demonstrate both novelty and inventive step over prior art, including existing patents, scientific literature, or public disclosures. The novelty may stem from unique structural features or application techniques not previously disclosed.
-
Potential Overlaps and Encroachments:
Existing patents in South Korea or international counterparts may overlap, especially in the same therapeutic area. Cross-reference searches could reveal prior art that potentially narrows or challenges the patent’s scope.
Claims Scope Limitations:
The claims must balance broad protection with defensibility. Overly broad claims risk rejection or invalidation, especially if prior similar disclosures are found, whereas narrowly drafted claims might be more resistant but offer limited exclusivity.
Patent Landscape in South Korea for Relevant Drug Classes
South Korea maintains a mature patent environment, especially strong in pharmaceuticals, with local filings often aligned with international patent strategies under the Patent Cooperation Treaty (PCT).
Key Trends and Strategies:
-
Active Patent Filings:
Pharmaceutical companies regularly file for both composition of matter patents and method of use patents, focusing on novel compounds and indications.
-
Patent Clusters:
Prior art search indicates clusters around specific therapeutic classes such as oncology, neurology, and infectious diseases.
-
Patent Life Cycle:
Many patents in this space have filing dates from the early 2010s, with a typical 20-year term, aligning with the KR20140081761 filing date.
Notable Related Patents:
-
Patents with similar claims often relate to kinase inhibitors, antiviral agents, or biologics. Potential overlaps could involve patents owned by South Korean or international entities, influencing freedom-to-operate assessments.
-
The patent landscape also features several formulation-related patents, which could impact the comprehensive protection of drug delivery systems.
Legal and Strategic Implications
Patentability and Enforcement:
Given the detailed nature of claims and the significant patent landscape, enforceability depends on the patent’s claim clarity and differentiation. Courts in South Korea are active in patent disputes, especially over biopharmaceutical patents, making strategic claim drafting vital.
Life Cycle Management:
Patent KR20140081761 can serve as a foundation for secondary patents—such as methods of treatment, polymorphs, or formulations—enhancing patent portfolio strength.
Freedom to Operate (FTO):
Comprehensive searches must be conducted considering publicly available patents in South Korea and global counterparts to mitigate infringement risks.
Conclusion
Patent KR20140081761 provides a targeted protective umbrella within South Korea's competitive pharmaceutical market. Its scope, defined by precise claims, centers on a specific compound or therapeutic use, aligned with strategic patent filing norms. Its strength hinges on claim breadth, novelty, and inventive step, with the broader patent landscape indicating active competition and innovation. Explorers of this patent should consider continuous monitoring of related patents and potential legal challenges to maximize strategic advantages.
Key Takeaways
- Scope is central: Precise drafting of claims determines the extent of protection; broad claims offer more comprehensive exclusivity but face increased scrutiny.
- Robust patent landscape: South Korea's active pharmaceutical patent environment demands meticulous prior art searches to ensure FTO and patent defensibility.
- Strategic positioning: Maintaining patent strength involves not only prosecution but also proactive lifecycle management through secondary patents.
- Risk management: Regular legal assessments are essential to identify potential overlaps or invalidation risks, especially with overlapping patents in therapeutic areas.
- Global consistency: Aligning South Korean patents with international filings enhances patent robustness and market coverage.
FAQs
1. What are the typical components of the claims in KR20140081761?
The claims likely cover the chemical structure of a novel compound, its pharmaceutical formulations, and therapeutic methods involving the compound, with dependent claims specifying particular variants or methods.
2. How does the scope of this patent compare to international patents in the same field?
While US and European patents might feature broader claims, KR20140081761's scope is tailored to South Korea’s patentability standards, possibly narrower but more enforceable domestically.
3. Can this patent be challenged or invalidated in South Korea?
Yes, through invalidation procedures based on prior art disclosures, lack of novelty, or obviousness, especially if prior patents or publications disclose similar inventions.
4. What should patent holders do to maximize the value of KR20140081761?
Palintiffs should pursue secondary patent protection (e.g., methods, formulations), monitor patent expiry, and enforce rights proactively against infringers.
5. How does the patent landscape influence drug development in South Korea?
The rich patent environment incentivizes innovation but requires strategic patent prosecution and licensing negotiations to navigate overlapping rights and maintain market exclusivity.
Sources:
- Korean Intellectual Property Office (KIPO). Patent KR20140081761.
- WIPO PATENTSCOPE and national patent databases.
- Market analysis reports on South Korea’s biotech and pharmaceutical sectors.
